Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-19
1997-09-02
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549407, A61K 3135, C07D31158
Patent
active
056631944
ABSTRACT:
Described herein are compounds of the formula: ##STR1## in which n is 1, 2 or 3; m is 0 or 1; and R is a substituted or unsubstituted phenyl group in which the substitutents are, independently, one or two members selected from the group consisting of alkyl, hydroxy, halo or amino groups or R is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms; or a pharmaceutically acceptable salt thereof, which are inhibitors of dopamine synthesis and release, and are useful in the treatment of schizophrenia, Parkinson's Disease, Tourette's Syndrome, alcohol addiction, cocaine addiction, and addiction to analagous drugs.
REFERENCES:
patent: 4321270 (1982-03-01), Sundeen
patent: 5126367 (1992-06-01), Stack et al.
patent: 5137901 (1992-08-01), Junge et al.
patent: 5318988 (1994-06-01), Schohe-Loop et al.
patent: 5371094 (1994-12-01), Heine et al.
Indian Journal of Chemistry, 20B, 12, 1063-1067, Dec. 1981.
Jackson Richard K.
Richter Johann
Stockton Laura L.
LandOfFree
Chroman-2-ylmethylamino derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chroman-2-ylmethylamino derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chroman-2-ylmethylamino derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308610